⌘K

Login Start Free

Home/Filings/4/0001864317-22-000007

4//SEC Filing

Katzoff David J 4

Accession 0001864317-22-000007

CIK 0001677077other

View on SEC.gov Company Profile

Filed

Sep 13, 8:00 PM ET

Accepted

Sep 14, 5:07 PM ET

Size

4.4 KB

Accession

0001864317-22-000007

Insider Transaction Report

Form 4

Period: 2022-09-14

Alzamend Neuro, Inc.ALZN

Katzoff David J

Chief Financial Officer

Transactions

Purchase
Common Stock
2022-09-14$1.11/sh+10,000$11,092→ 28,000 total

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Alzamend Neuro, Inc.

CIK 0001677077

Entity typeother

Related Parties

1

filerCIK 0001864317

Filing Metadata

Form type: 4
Filed: Sep 13, 8:00 PM ET
Accepted: Sep 14, 5:07 PM ET
Size: 4.4 KB

View on SEC.gov